P. Sleight

S. Yusuf, J. Bosch, G. Dagenais, 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Trandolapril Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use in Essential Hypertension

T. Ogihara, P. Sleight, T. Ishizaki, 1994 .

Time course of haemodynamic changes after maximal exercise

M. Piepoli, S. Adamopoulos, A. Coats, 1994, European journal of clinical investigation.

Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.

R. Collins, B. Davis, C. Bulpitt, 1998, Journal of hypertension.

Use of beta adrenoceptor blockade during and after acute myocardial infarction.

P. Sleight, 1986, Annual review of medicine.

Prophylactic antibiotics for cardiac pacemaker implantation. A prospective trail.

A. Arnold, M. Muers, P. Sleight, 1981, British heart journal.

Diminished baroreflex sensitivity in high blood pressure and ageing man.

A. J. Honour, T. Pickering, J. Bristow, 1969, The Journal of physiology.

Telmisartan in high-risk patients intolerant of ACE inhibitors – Authors' reply

S. Yusuf, J. Pogue, C. Anderson, 2009, The Lancet.

EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTION Preliminary Report of a Randomised Trial

R. Peto, S. Yusuf, D. Ramsdale, 1980, The Lancet.

Short term and long term effects of alcohol on blood pressure, cardiovascular risk and all cause mortality.

P. Sleight, 1996, Blood pressure.

Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial

S. Yusuf, P. Gao, C. Anderson, 2013, Journal of hypertension.

Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial

S. Yusuf, A. Acquaviva, P. Poole‐Wilson, 2017, Journal of the American Heart Association.

Heart rate and ectopic prematurity in relation to sustained ventricular arrhythmias.

S. Yusuf, P. Sleight, R. Lopez, 1980, British heart journal.

Baroreflex sensitivity and heart rate variability as predictors of cardiovascular outcome in hypertensive patients with multiple risk factors for coronary disease

P. Sleight, L. Bernardi, J. Angell-James, 2001, Journal of Human Hypertension.

The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension

P. Sleight, AndrewJ. S. Coats, A. Radaelli, 1992, Journal of hypertension.

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease.

S. Yusuf, J. Bosch, G. Dagenais, 2004, European heart journal.

Should post-infarction asymptomatic ventricular arrhythmias be treated? The need for caution.

P. Sleight, 1995, European heart journal.

The HOPE study: comparison with other trials of secondary prevention.

P. Sleight, J. Otterstad, 2001, European heart journal.

Angiotensin Antagonism Effect of Long-Term Therapy With Ramipril in High-Risk Women

S. Yusuf, J. Bosch, G. Dagenais, 2016 .

Effect of long-term therapy with ramipril in high-risk women.

S. Yusuf, J. Bosch, G. Dagenais, 2002, Journal of the American College of Cardiology.

The HOPE Study (Heart Outcomes Prevention Evaluation)

P. Sleight, Peter Sleight, 2000, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Antiarrhythmic Properties of Beta-Adrenoceptor Blockade During and After Myocardial Infarction

P. Sleight, P. Rossi, 1989 .

Regular coffee consumption increased mean 24-hour ambulatory blood pressure in older men and women

P. Sleight, 1999 .

Health Services and Outcomes Research Influenza Vaccination and Major Adverse Vascular Events in High-Risk Patients

S. Yusuf, Li-sheng Liu, P. Gao, 2012 .

Power Spectral Analysis of Heart Rate Variability and Baroreflex Gain: Author's Reply

L. Tavazzi, R. Maestri, G. Pinna, 1995 .

Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training.

P. Ponikowski, M. Piepoli, S. Adamopoulos, 1995, European heart journal.

31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure.

S. Frostick, G. Radda, B. Rajagopalan, 1987, The American journal of cardiology.

Smoking and hypertension.

P. Sleight, 1993, Clinical and experimental hypertension.

THE DIAGNOSIS AND TREATMENT OF AORTIC STENOSIS COMPLICATED BY HEART BLOCK

P. Sleight, A. Harris, C. Drew, 1965, British heart journal.

QT interval dynamics and heart rate variability preceding a case of cardiac arrest.

P. Sleight, A. Kardos, G. Hart, 1997, Heart.

Effects of physical training in chronic heart failure

S. Adamopoulos, A. Coats, P. Sleight, 1990, The Lancet.

Experience from controlled trials of physical training in chronic heart failure. Protocol and patient factors in effectiveness in the improvement in exercise tolerance. European Heart Failure Training Group.

P. Ponikowski, D. Paterson, S. Scalvini, 1998, European heart journal.

Who is fooling us?

S. Yusuf, P. Sleight, 2002, The Lancet.

Heart Protection Study

R. Collins, R. Peto, S. Parish, 2003, The Lancet.

Angiotensin II and trials of cardiovascular outcomes.

P. Sleight, 2002, The American journal of cardiology.

Enthusiasm, reality, and cost-effectiveness analysis

J. Brophy, P. Sleight, 1998, Heart.

European Society of Hypertension Scientific Newsletter, Update on Hypertension Management: Treatment of hypertension in patients with type‐2 diabetes mellitus

S. Kjeldsen, J. Mallion, L. Hansson, 2000 .

A Napoleonic future for cardiology?

P. Sleight, PETER SLEIGHT, 1999, Heart.

How much should blood pressure be lowered? The problem of the J-shaped curve.

A. Zanchetti, A. Amery, L. Hansson, 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Preventing stroke with ramipril—authors' reply

S. Yusuf, P. Sleight, Jacqueline Bosch, 2003, BMJ : British Medical Journal.

Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.

A. Zanchetti, H. Black, J. Wittes, 1998, Controlled clinical trials.

Impact of CKD on Household Income

M. Landray, R. Collins, B. Kasiske, 2017, Kidney international reports.

Cognitive impairment and risk of cardiovascular events and mortality.

S. Yusuf, J. Bosch, P. Gao, 2012, European heart journal.

S12. Music and the autonomic nervous system S12.1 Dynamic interactions between musical, cardiovascular and cerebral rhythms in man

P. Sleight, L. Bernardi, C. Porta, 2009, Autonomic Neuroscience.

Angina and Coronary Artery Disease in Patients with Aortic valve Disease

S. Adamopoulos, G. Kolovou, D. Alexopoulos, 1993, Angiology.

Lowering of blood pressure and artery stiffness

P. Sleight, 1997, The Lancet.

Lowering of blood pressure and artery stiffness

P. Sleight, 1997, The Lancet.

BLOOD PRESSURES, HEARTS, AND U-SHAPED CURVES

P. Sleight, 1988, The Lancet.

Smoking and Ischaemic Heart Disease

P. Sleight, 1999 .

Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study.

J. Bosch, G. Dagenais, E. Lonn, 2005, Clinical nephrology.

Hemodynamics in hypertension and heart failure.

P. Sleight, 1984, The American journal of medicine.

Coronary Circulation and Myocardial Ischaemia: Thrombolysis

P. Sleight, 2002 .

Calcium Antagonists During and After Myocardial Infarction

P. Sleight, 1996, Drugs.

Baroreflex sensitivity and the blood pressure response to β-blockade

P. Sleight, X. Chen, J. Floras, 1999, Journal of Human Hypertension.

Effects on ventricular arrhythmias of oral captopril and of oral mononitrate started early in acute myocardial infarction: results of a randomised placebo controlled trial.

R. Collins, M. Flather, P. Sleight, 1993, British heart journal.

The secondary prevention of myocardial infarction by drug treatment; excluding lipid lowering agents.

P. Sleight, 1992, Clinical and experimental hypertension. Part A, Theory and practice.

Early Intravenous β-adrenoceptor blockade for victims of heart attack Peter Sleight

P. Sleight, 1988 .

Beta blockade early in acute myocardial infarction.

P. Sleight, 1987, The American journal of cardiology.

Variability of electrocardiographic and enzyme evolution of myocardial infarction in man.

S. Yusuf, P. Sleight, R. Lopez, 1981, British heart journal.

Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.

R. Peto, S. Yusuf, D. Ramsdale, 1983, Circulation.

Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.

S. Yusuf, D. Ramsdale, P. Sleight, 1983, British medical journal.

EFFECT OF ATENOLOL ON RECOVERY OF THE ELECTROCARDIOGRAPHIC SIGNS OF MYOCARDIAL INFARCTION

S. Yusuf, P. Sleight, R. Lopez, 1979, The Lancet.

Ischemic pain relief in patients with acute myocardial infarction by intravenous atenolol.

E. Faragher, S. Yusuf, D. Ramsdale, 1982, American heart journal.

Beta-blockade in acute myocardial infarction.

P. Sleight, 1982, Advances in cardiology.

The risk of stroke after thrombolytic therapy.

A. Maggioni, P. Sleight, R. Collins, 1992, New England Journal of Medicine.

Small versus large cardiovascular trials

P. Sleight, 1990 .

Significance of elevated MB isoenzyme with normal creatine kinase in acute myocardial infarction.

R. Collins, S. Yusuf, P. Sleight, 1987, The American journal of cardiology.

Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

R. Collins, S. Willich, R. Peto, 1992, European heart journal.

Left ventricular hypertrophy in hypertensive patients is associated with abnormal rate adaptation of QT interval.

J. Johnston, P. Sleight, G. Hart, 1997, Journal of the American College of Cardiology.

Overutilization and underutilization of thrombolysis in routine clinical practice.

P. Sleight, 2001, Journal of the American College of Cardiology.

The reflex regulation of arterial pressure during sleep in man.

G. Pickering, P. Sleight, H. Smyth, 1968, The Journal of physiology.

Investigating modifications to participant information materials to improve recruitment into a large randomized trial

M. Landray, R. Collins, K. Rahimi, 2019, Trials.

From clinical trials to clinical practice

P. Sleight, 1995 .

Limitation of Myocardial Infarct Size

S. Yusuf, P. Sleight, 1983, Drugs.

Early Intravenous Atenolol in Suspected Acute Myocardial Infarction: Final Report of a Randomised Clinical Trial

R. Peto, S. Yusuf, D. Ramsdale, 1984 .

INFARCTION: FINAL REPORT OF A RANDOMISED CLINICAL TRIAL

R. Peto, S. Yusuf, S. Parish, 1984 .

The relation of arterial pressure to sleep and arousal in man.

G. Pickering, P. Sleight, H. Smyth, 1967, The Journal of physiology.

Continuous Recording of Direct Arterial Pressure and Electrocardiogram in Unrestricted Man

A. J. Honour, F. D. Stott, W. Littler, 1972, British medical journal.

Direct arterial pressure, pulse rate, and electrocardiogram during micturition and defecation in unrestricted man.

A. J. Honour, W. Littler, P. Sleight, 1974, American heart journal.

Direct arterial pressure, heart rate and electrocardiogram during human coitus.

A. J. Honour, W. Littler, P. Sleight, 1974, Journal of reproduction and fertility.

Action potentials in fibres from receptors in the epicardium and myocardium of the dog's left ventricle.

P. Sleight, J. Widdicombe, 1965, The Journal of physiology.

Is angiotensin a prime factor in blood pressure control?

P. Sleight, 1982, The American journal of cardiology.

Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity.

J. Floras, M. Hassan, P. Sleight, 1985, Journal of the American College of Cardiology.

Importance of cardiovascular reflexes in disease.

P. Sleight, 1988, The American journal of medicine.

Evidence for Abnormalities Unrelated to Blood Flow

S. Frostick, G. Radda, B. Rajagopalan, 2005 .

Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow.

S. Frostick, G. Radda, B. Rajagopalan, 1988, Circulation.

Impact of Cigarette Smoking in High-Risk Patients Participating in a Clinical Trial. A Substudy from the Heart Outcomes Prevention Evaluation (HOPE) Trial

S. Yusuf, G. Dagenais, E. Lonn, 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Controlled Trial of Physical Training in Chronic Heart Failure: Exercise Performance, Hemodynamics, Ventilation, and Autonomic Function

S. Adamopoulos, A. Coats, P. Sleight, 1992, Circulation.

Exercise and the heart.

P. Sleight, 1992, Australian and New Zealand journal of medicine.

Postexercise Hypotension Is Not Sustained in Normal and Hypertensive Humans

V. Somers, P. Sleight, J. Conway, 1991, Hypertension.

Cardiac and blood pressure responses to mental stress in reactive hypertensives.

A. Coats, P. Sleight, J. Conway, 1991, Clinical and experimental hypertension. Part A, Theory and practice.

EARLY REHABILITATION AFTER MYOCARDIAL INFARCTION

P. Sleight, R. Mayou, D. Macmahon, 1981, The Lancet.

Effects of endurance training on baroreflex sensitivity and blood pressure in borderline hypertension

V. Somers, J. Johnston, P. Sleight, 1991, The Lancet.

The influence of arterial baroreceptors in man on the variability of blood pressure and plasma catecholamines in man.

P. Sleight, 1983, Chest.

Effects of Anesthesia on Baroreflex Control of Heart Rate in Man

T. Pickering, J. Bristow, P. Sleight, 1969, Anesthesiology.

The influence of ventilation, carbon dioxide and hypoxia on the baroreceptor reflex in man.

D. J. Cunningham, J. Bristow, E. Brown, 1968, The Journal of physiology.

Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.

J. Chesebro, P. Sleight, L. Harker, 1986, European heart journal.

Cholesterol and coronary heart disease mortality.

P. Sleight, 1992, Australian and New Zealand journal of medicine.

Baroreceptor firing frequency and activation of carotid sinus vascular smooth muscle in dogs [proceedings].

D. Bergel, P. Sleight, D. Brooks, 1978, The Journal of physiology.

The action of clonidine on the baroreflex control of heart rate in conscious animals and man, and on single aortic baroreceptor discharge in the rabbit.

J. Chalmers, P. Korner, P. Sleight, 1975, Archives internationales de pharmacodynamie et de therapie.

Reperfusion in acute myocardial infarction

E. Rapaport, M. Simoons, B. Pitt, 2005, Drug and therapeutics bulletin.

Skeletal muscle metabolism in heart failure: a 31P nuclear magnetic resonance spectroscopy study of leg muscle.

G. Radda, B. Rajagopalan, P. Sleight, 1990, Clinical science.

Interventions During and After Acute Myocardial Infarction

P. Sleight, 2012, Drugs.

Lisinopril Review of its Pharmacology and Clinical Efficacy in Elderly Patients

J. Tamargo, P. Sleight, L. Lisheng, 1997 .

Ventricular arrhythmias in long term survivors of orthotopic and heterotopic cardiac transplantation.

M. Yacoub, S. Yusuf, D. Alexopoulos, 1988, British heart journal.

hypothesis of instability of the chemoreflex loop Periodic breathing in heart failure patients: testing the

A. Hughes, J. Richalet, A. Pichon, 2015 .

Impulses in Slowly Conducting Vagal Fibers from Afferent Endings in the Veins, Atria, and Arteries of Dogs and Cats

P. Sleight, H. Coleridge, J. Coleridge, 1973, Circulation research.

Reflex Cardiovascular Effects of Epicardial Stimulation by Acetylstrophanthidin in Dogs

M. Muers, P. Sleight, M. Muers, 1969, Circulation research.

Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.

M. Piepoli, S. Adamopoulos, A. Coats, 1995, Lancet.

The reflex cardiovascular depression caused by occlusion of the coronary sinus in the dog

M. Muers, P. Sleight, 1972, The Journal of physiology.

Action potentials from ventricular mechanoreceptors stimulated by occlusion of the coronary sinus in the dog

M. Muers, P. Sleight, 1972, The Journal of physiology.

Ventilation in chronic heart failure: effects of physical training

S. Adamopoulos, A. Coats, B. Casadei, 1992, British heart journal.

The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents.

A. Coats, V. Somers, J. Johnston, 1988, Journal of hypertension.

New Trial Data on Prevention: Potassium and CV Risk in Hope

S. Yusuf, J. Bosch, G. Dagenais, 2003 .

Baroreflex control of blood pressure and plasma noradrenaline during exercise in essential hypertension.

J. Floras, P. Sever, M. Hassan, 1979, Clinical science.

Do we need to intervene after thrombolysis in acute myocardial infarction?

P. Sleight, 1990, Circulation.

The effects of hypoxia, hypercapnia, and asphyxia on the baroreceptor-cardiac reflex at rest and during exercise in man.

D. J. Cunningham, T. Pickering, P. Sleight, 1972, Acta physiologica Scandinavica.

Mechanisms concerned with blood pressure variability throughout the day.

P. Sleight, N. Boon, J. Conway, 1985, Clinical and experimental hypertension. Part A, Theory and practice.

Prior blunt chest trauma may be a cause of single vessel coronary disease; hypothesis and review.

P. Sleight, Mette Christensen, Poul Ebbe Nielsen, 2006, International journal of cardiology.

Persistent peripheral vasodilation and sympathetic activity in hypotension after maximal exercise.

M. Piepoli, S. Adamopoulos, A. Coats, 1993, Journal of applied physiology.

Effects of the angiotensin receptor blocker, telmisartan, on cardiovascular events in high-risk patients intolerant to ACE-inhibitors. Erratum of Vol 372(9644):1174-83

S. Yusuf, J. Pogue, C. Anderson, 2008 .

Skeletal muscle metabolism in experimental heart failure: Effects of infarct size and physical training

G. Radda, B. Rajagopalan, S. Adamopoulos, 1991 .

Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONT

S. Yusuf, G. Dagenais, Li-sheng Liu, 2010, Circulation.

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials

Barry J. Davis, M. Landray, R. Collins, 2022, The Lancet.

Hyponatremia and Ultramarathons

V. Somers, S. Bloom, P. Sleight, 1986 .

Circadian Variation and Waking Hour Dynamics of the QT Interval

Jagmeet P. Singh, B. Casadei, J. Johnston, 1997 .

Teaching communication skills: part of medical education?

P. Sleight, 1995, Journal of human hypertension.

New methods for risk stratification in patients after myocardial infarction autonomic control and substrate sensitivity.

P. Sleight, 2007, Journal of the American College of Cardiology.

RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION

R. Collins, P. Sleight, 1987 .

Ramipril Global Endpoint Trial / Telmisartan Randomized AssessmeNt Study in ACE withTelmisartan , Ramipril , or Both : The ONgoing Telmisartan Alone and in combination Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving

S. Yusuf, G. Dagenais, Li-sheng Liu, 2010 .

Diurnal variations of QT interval after cardiac transplantation.

M. Yacoub, S. Yusuf, A. Rynkiewicz, 1988, The American journal of cardiology.

ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.

R. Collins, R. Peto, S. Parish, 1993, The American journal of cardiology.

Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.

P. Sleight, J. Raine, M. Palazzo, 1981, British medical journal.

Chronic Coronary Artery Disease Predictors of Adverse Outcome Among Patients With Hypertension and Coronary Artery Disease

P. Kowey, G. Mancia, L. Tavazzi, 2006 .

Ambulatory Blood Pressure and its Variability During Randomised Double-blind Administration of Atenolol, Metoprolol, Pindolol and Long Acting Propranolol in Subjects with Mild to Moderate Hypertension

J. Floras, M. Hassan, P. Sleight, 1983, Drugs.

CIRCULATORY CHANGES IN ANGINA Table 2 A Summary of the Changes Accompanying Each Individual Anginal Attack

A. J. Honour, F. D. Stott, W. Littler, 2005 .

Ambulatory blood pressure monitoring.

P. Sleight, 1985, Hypertension.

Blood pressure variability in patients on beta-blockers.

A. J. Honour, W. Littler, P. Sleight, 1976, Australian and New Zealand journal of medicine.

Continuous recording of direct arterial pressure in unrestricted patients. Its role in the diagnosis and management of high blood pressure.

A. J. Honour, W. Littler, P. Sleight, 1975, Circulation.

Direct Arterial Pressure and the Electrocardiogram in Unrestricted Patients with Angina Pectoris

A. J. Honour, F. D. Stott, W. Littler, 1973, Circulation.

Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures.

S. Yusuf, P. Gao, K. Teo, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Severe paroxysmal hypertension induced by a subconscious Valsalva-like manoeuvres

P. Sleight, J. Conway, Poul Ebbe Nielsen, 1992, Clinical Autonomic Research.

What happened to intravenous atenolol in acute myocardial infarction?

P. Sleight, 1994, Cardiology.

Critical assessment of diagnostic value of endomyocardial biopsy. Assessment of cardiac biopsy.

W. Littler, P. Sleight, E. H. Mackay, 1978, British heart journal.

Cardiovascular effects of music by entraining cardiovascular autonomic rhythms music therapy update: tailored to each person, or does one size fit all?

P. Sleight, 2013, Netherlands Heart Journal.

Arousal and the circadian rhythm of blood pressure.

J. Floras, M. Hassan, J. Johnston, 1978, Clinical science and molecular medicine. Supplement.

Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis

S. Yusuf, M. Böhm, R. Schmieder, 2014, Journal of hypertension.

SAFETY AND EFFICACY OF AGGRESSIVE BLOOD PRESSURE LOWERING AMONG PATIENTS WITH DIABETES: SUBGROUP ANALYSES FROM THE ONTARGET TRIAL

S. Yusuf, J. Pogue, P. Gao, 2009 .

The role of serum myoglobin in the detection and measurement of myocardial infarction.

S. Yusuf, P. Sleight, R. Lopez, 1980, Clinica chimica acta; international journal of clinical chemistry.

Focus on thrombolytic therapy.

P. Sleight, 1997, Evidence-based cardiovascular medicine.

Value ofelectrocardiogra m inpredicting andestimating infarct sizeinman

S. Yusuf, P. Sleight, R. Lopez, 1979 .

Thrombolysis: state of the art.

P. Sleight, 1993, European heart journal.

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial

P. Grambsch, A. Zanchetti, H. Black, 2001, Hypertension.

Prevalence and persistence of breathing disorders in chronic heart failure patients: preliminary results from home telemonitoring in the HHH study

M. Emdin, A. di Lenarda, R. Maestri, 2005, Computers in Cardiology, 2005.

Long-term monitoring of sleep apnea at home in heart failure patients: preliminary results from the HHH study

M. Emdin, A. di Lenarda, R. Maestri, 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

Blood pressure levels for treatment of uncomplicated diabetes in primary care.

P. Sleight, 2013, Journal of hypertension.

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions

R. Collins, R. Peto, S. Parish, 2004, The Lancet.

Evaluation of organ damage in hypertension.

A. Zanchetti, P. Sleight, W. Birkenhäger, 1993, Journal of hypertension.

Book Review: ISAM 1979: Proceedings of the Third International Symposium on Ambulatory Monitoring

P. Sleight, 1981 .

Healthy eating and reduced risk of cognitive decline

S. Yusuf, G. Dagenais, P. Gao, 2015, Neurology.

Early and late changes in left ventricular filling after acute myocardial infarction and the effect of infarct size.

M. Flather, P. Sleight, T. Meyer, 1992, The American journal of cardiology.

Consequences of impaired arterial baroreflexes in essential hypertension: effects on pressor responses, plasma noradrenaline and blood pressure variability.

J. Floras, P. Sever, M. Hassan, 1988, Journal of hypertension.

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease

S. Yusuf, J. Bosch, P. Sleight, 2004 .

Orthostatic hypertension.

P. N. Chhuttani, M. Sambhi, P. Sleight, 1979, The American journal of medicine.

The baroreflex bandwagon: time to get off?

P. Sleight, 2001 .

Reduction in Infarct Size, Arrhythmias, Chest Pain and Morbidity by Early Intravenous β-Blockade in Suspected Acute Myocardial Infarction

R. Peto, S. Yusuf, D. Ramsdale, 2012, Drugs.

Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Peter Sleight, Janet Wittes, James D Neaton, 2003, JAMA.

We could all learn from the Italian cardiologists.

P. Sleight, 2004, American heart journal.

Arterial baroreflexes can determine long-term blood pressure. Baroreceptors and hypertension: time for a re-think?

P. Sleight, 2004, Experimental physiology.

Vitamin E supplementation and cardiovascular events in high-risk patients.

S. Yusuf, J. Bosch, G. Dagenais, 2000, The New England journal of medicine.

Orthostatic hypertension.

P. N. Chhuttani, M. Sambhi, P. Sleight, 1979, The American journal of medicine.

Wider inclusion criteria needed for thrombolytic therapy.

R. Peto, P. Sleight, R. Collins, 1989, Annals of internal medicine.

New analyses of Heart Protection Study

R. Collins, R. Peto, S. Parish, 2004, The Lancet.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

M. Landray, R. Collins, B. Kasiske, 2011, The Lancet.

ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

David Hunt, P Armitage, Sarah Parish, 1992 .

Blood Pressure Control During Mental Stress

P. Sleight, N. Boon, J. Conway, 1984 .

Lack of peripheral modulation of cardiovascular central oscillatory autonomic activity during apnea in humans.

P. Sleight, L. Bernardi, C. Passino, 1997, The American journal of physiology.

Ambulatory Blood Pressure Values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)

S. Yusuf, P. Gao, G. Parati, 2012, Hypertension.

The diagnosis of hypertension.

P. Sleight, 1971, The Practitioner.

The cardiovascular effects of coronary sinus distension in the anaesthetised dog.

M. Muers, P. Sleight, 1972, Quarterly journal of experimental physiology and cognate medical sciences.

Reperfusion in acute myocardial infarction. International Society and Federation of Cardiology and World Health Organization Task Force on Myocardial Reperfusion.

E. Rapaport, M. Simoons, B. Pitt, 1994, Circulation.

Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients.

G. de Simone, D. Vanuzzo, A. Maggioni, 2003, Italian heart journal : official journal of the Italian Federation of Cardiology.

Stress Factors in Angina Pectoris

P. Sleight, 1977, Scottish medical journal.

Atrial septostomy.

P. Sleight, D. Pickering, J. Hamill, 1968, British medical journal.

Urinary sodium and potassium excretion and risk of cardiovascular events.

S. Yusuf, A. Dans, P. Gao, 2011, JAMA.

The role of baroreflex sensitivity in post-exercise hypotension.

V. Somers, P. Sleight, J. Conway, 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Assessment of the antihypertensive effect of atenolol with 24 h ambulatory monitoring of blood pressure.

J. Floras, M. Hassan, P. Sleight, 1979, Clinical science.

The Variability of Arterial Pressure

A. J. Honour, W. Littler, P. Sleight, 1979 .

Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial)

M. Barman, B. Prendergast, G. Angelini, 2018, Journal of the American Heart Association.

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.

R. Collins, R. Peto, C. Baigent, 1997, The New England journal of medicine.

Reflex Regulation of Arterial Pressure during Sleep in Man: A Quantitative Method of Assessing Baroreflex Sensitivity

G. Pickering, P. Sleight, H. Smyth, 1969, Circulation research.

New evidence on the importance of the renin–angiotensin system in the treatment of higher-risk patients with hypertension

S. Yusuf, P. Sleight, 2003, Journal of hypertension.

Use of ramipril in preventing stroke: double blind randomised trial

J. Bosch, J. Pogue, E. Lonn, 2002, BMJ : British Medical Journal.

Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures: A HOPE Substudy

U. de Faire, S. Yusuf, P. Sleight, 2001, Hypertension.

After the diagnosis of systemic hypertension, is risk factor management important?

P. Sleight, 1992, The American journal of cardiology.

Cardiovascular risk factors and the effects of intervention.

P. Sleight, 1991, American heart journal.

1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting.

C. I. Johnston, Giuseppe Mancia, Anthony F. Lever, 1989, Bulletin of the World Health Organization.

The role of angiotensinconverting enzyme inhibitors in the treatment of hypertension

P. Sleight, 2001, Current cardiology reports.

Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study

N R Hicks, J. Newton, P. Sleight, 1998, Heart.

Candida Endocarditis Treated with 5-Fluorocytosine

P. Sleight, D. Speller, C. Record, 1971, British medical journal.

Characteristics of single carotid sinus baroreceptor fibers and whole nerve activity in the normotensive and the renal hypertensive dog.

P. Sleight, D. Brooks, J. L. Robinson, 1977, Circulation research.

Effect of Age and High Blood Pressure on Barorefiex Sensitivity in Man

R Peto, R. Peto, T. Pickering, 1971, Circulation research.

Alcohol consumption and the risk of incident atrial fibrillation among people with cardiovascular disease

S. Yusuf, Jun Zhu, P. Gao, 2012, Canadian Medical Association Journal.

ATRIAL SEPTOSTOMY BY BALLOON CATHETER

P. Sleight, A. Gunning, H. Ellis, 1967 .

Benefits, challenges, and registerability of the polypill.

F. Zannad, P. Sleight, H. Pouleur, 2006, European heart journal.

A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease

Mark I. McCarthy, Philippe Froguel, Paul Elliott, 2011, Nature Genetics.

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

John Fuller, Luigi Tavazzi, John Wikstrand, 2019, The Lancet.

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

Barry J. Davis, R. Collins, A. Keech, 2015, The Lancet.

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

J. Danesh, R. Collins, R. Peto, 2000, The Lancet.

Cardiovascular and respiratory changes during sleep in normal and hypertensive subjects.

A. J. Honour, T. Pickering, J. Bristow, 1969, Cardiovascular research.

The Lability of Blood Pressure

J. Floras, P. Sleight, 1982 .

Comparison of the reflex heart rate response to rising and falling arterial pressure in man.

T. Pickering, P. Sleight, P Sleight, 1972, Cardiovascular research.

Methodology of baroreflex testing.

P. Sleight, 1992, Giornale italiano di cardiologia.

REFLEX CARDIAC ARREST IN TETRAPLEGIA

C. Mathias, H. Frankel, J. Spalding, 1976, The Lancet.

CUFF AND AMBULATORY BLOOD PRESSURE IN SUBJECTS WITH ESSENTIAL HYPERTENSION

P. Sever, J. Floras, P. Sever, 1981, The Lancet.

The measurement of arterial pressure, carotid sinus radius and baroreflex sensitivity in the conscious greyhound [proceedings].

D. Bergel, P. Sleight, J. L. Robinson, 1979, The Journal of physiology.

Ambulatory pressure monitoring in the assessment of antihypertensive therapy

A. Coats, V. Somers, P. Sleight, 1989, Cardiovascular Drugs and Therapy.

AMBULATORY BLOOD-PRESSURE

B. Gould, D. Altman, E. Raftery, 1981, The Lancet.

Haemodynamic Changes During Sleep in Man

P. Sleight, H. Smyth, J. Jones, 1982 .

Failure of plasma norepinephrine to consistently reflect sympathetic activity in humans.

J. Floras, P. Sever, M. Hassan, 1986, Hypertension.

The effects of hypercapnia, hypoxia and ventilation on the baroreflex regulation of the pulse interval

E B Brown, D. J. Cunningham, J. Bristow, 1971, The Journal of physiology.

Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies

S. Yusuf, K. Sliwa, E. Lonn, 2015, Journal of internal medicine.

A historical perspective on peripheral reflex cardiovascular control from animals to man

P. Sleight, 2014, Experimental physiology.

Cardiac vomiting.

P. Sleight, 1981, British heart journal.

Occasional survey Cardiac vomiting

P. Sleight, 2022 .

Baroreflex control of stroke volume in man: an effect mediated by the vagus.

J Conway, B. Casadei, P. Sleight, 1992, The Journal of physiology.

Effects of Autonomic Blockade on the Baroreflex in Man at Rest and During Exercise

D. J. Cunningham, T. Pickering, P. Sleight, 1972, Circulation research.

The effects of raising alveolar PCO2 and ventilation separately and together on the sensitivity and setting of the baroreceptor cardiodepressor reflex in man

D. J. Cunningham, T. Pickering, J. Bristow, 1974, The Journal of physiology.

Quantitative index of baroreflex activity in normal and hypertensive subjects using Valsalva's manoeuvre.

T. Pickering, P. Sleight, 1969, British heart journal.

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

S. Yusuf, J. Bosch, G. Dagenais, 2005, JAMA.

SIGNIFICANT REDUCTION IN MORTALITY WITH STREPTOKINASE GIVEN 7-24 HOURS AFTER PAIN ONSET

R. Collins, R. Peto, P. Sleight, 1988, The Lancet.

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial

R. Collins, R. Peto, S. Parish, 2002 .

Blood-pressure reduction and cardiovascular risk in HOPE study

Salim Yusuf, Peter Sleight, Janice Pogue, 2001, The Lancet.

Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration.

M. Pfeffer, P. Macfarlane, A. Gotto, 1995, The American journal of cardiology.

Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease.

Michael Böhm, Helmut Schumacher, Salim Yusuf, 2013, American heart journal.

UNILATERAL ELEVATION OF THE INTERNAL JUGULAR PULSE

P. Sleight, 1962, British heart journal.

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

S. Yusuf, G. Dagenais, J. Pogue, 2008, The Lancet.

Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studie

S. Yusuf, G. Dagenais, A. Dans, 2012, Journal of hypertension.

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither

R. Collins, R. Peto, C. Baigent, 1998, BMJ.

ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction

Raymond C. Schneider, R. Collins, M. Keltai, 1995, The Lancet.

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group.

R. Collins, M. Pfeffer, S. Yusuf, 1998, Circulation.

Cardiovascular protection for all individuals at high risk: evidence-based best practice

M. Laakso, G. Dagenais, H. Diener, 2008, Clinical Research in Cardiology.

Proceedings: Assessment of value of catheter biopsy of the heart.

W. Littler, P. Sleight, E. H. Mackay, 1974, British heart journal.

Karatzas , Hamill , and Sleight 2

P. Sleight, N. Karatzas, J. Hamill, 2003 .

Hypertrophic cardiomyopathy.

P. Sleight, N. Karatzas, J. Hamill, 1968, British heart journal.

Low resting heart rates are associated with new‐onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies

S. Yusuf, K. Sliwa, E. Lonn, 2015, Journal of internal medicine.

Early intravenous atenolol treatment in suspected acute myocardial infarction.

R. Peto, S. Yusuf, D. Ramsdale, 2009, Acta medica Scandinavica. Supplementum.

Treatment of chronic heart block with the Lucas induction coil pacemaker.

P. Sleight, A. Gunning, C. Record, 1971, British heart journal.

Effect of atenolol or metoprolol on waking hour dynamics of the QT interval in myocardial infarction.

P. Sleight, P. Musialek, P. Davey, 1998, The American journal of cardiology.

The 2013 ESH/ESC guidelines for the management of arterial hypertension

Helmut Baumgartner, Jens Jordan, Michael Böhm, 2013 .

Computerized analysis of ambulatory monitoring in the quantification of sinoatrial disease

R. Stables, P. Sleight, J. A. Bond, 1994, Clinical Autonomic Research.

Arterial distensibility in normal and hypertensive man.

T. Pickering, P. Sleight, B. Gribbin, 1979, Clinical science.

Load dependence of changes in forearm and peripheral vascular resistance after acute leg exercise in man.

M. Piepoli, S. Adamopoulos, P. Sleight, 1994, The Journal of physiology.

Systemic and forearm vascular resistance changes after upright bicycle exercise in man.

V. Somers, P. Sleight, J. Conway, 1989, The Journal of physiology.

Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain?

R Maestri, L Bernardi, L. Tavazzi, 1995, Clinical science.

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

M. Landray, R. Collins, B. Kasiske, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.

R. Collins, R. Peto, K. Rahimi, 2010, JAMA.

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

M. Landray, R. Collins, R. Peto, 2013, European heart journal.

CORRESPONDENCF SECTION Platelet a-adrenoreceptors in borderline and established essential hypertension

P. Sleight, N. Boon, J. Jones, 1983 .

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation

M. Landray, R. Collins, B. Kasiske, 2017, Kidney international.

Speed of action of aspirin, soluble aspirin, and buffered aspirin.

P. Sleight, 1960, Lancet.

Effect of once-daily atenolol on ambulatory blood pressure.

J. Floras, M. Hassan, P. Sleight, 1979, British medical journal.

Ameet Bakhai, William Wijns, Jean Booth, 2002, The Lancet.

Clinical relevance of short‐term day‐time breathing disorders in chronic heart failure patients

R. Maestri, M. L. La Rovere, A. Mortara, 2007, European journal of heart failure.

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals

Karl Swedberg, Richard B. Devereux, Ralph L. Sacco, 2011, Journal of hypertension.

PPOGRESS beyond HOPE and LIFE: The ONTARGET trial programme

P. Sleight, 2003 .

Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor

P. Sleight, 2009, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Int

S. Yusuf, J. Pogue, C. Anderson, 2004, American heart journal.

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

P. Sleight, 2000, Current controlled trials in cardiovascular medicine.

Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.

S. Yusuf, S. Mcmahon, P. Held, 1990, Circulation.

Thrombolysis in Acute Myocardial Infaction: Lessons from ISIS‐2

P. Sleight, 1988 .

Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction.

R. Collins, R. Peto, S. Adamopoulos, 1991, British heart journal.

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

R. Collins, B. Davis, M. Pfeffer, 2021, The Lancet.

Is there an age limit for thrombolytic therapy?

P. Sleight, 1993, The American journal of cardiology.

Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials.

P. Sleight, L. Hilbrich, Lutz Hilbrich, 2006, European heart journal.

Trials and tribulations: the ISIS experience.

P. Sleight, 1992, Australian and New Zealand journal of medicine.

Selection of reperfusion therapy for individual patients with evolving myocardial infarction.

R. Collins, R. Califf, E. Steyerberg, 1997, European heart journal.

Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: a randomized placebo-controlled study.

R. Collins, M. Flather, P. Sleight, 1993, Journal of the American College of Cardiology.

Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure.

D. M. Barr, D. F. Hughes, R. Collins, 1996, Controlled clinical trials.

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

R. Collins, B. Davis, M. Pfeffer, 2021, The Lancet.

Cholesterol and total mortality: need for larger trials.

L Wilhelmsen, R Peto, R. Peto, 1992, BMJ.

Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme.

S. Yusuf, C. Anderson, H. Gerstein, 2009, Diabetes research and clinical practice.

Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

B. Davis, R. Holman, C. Bulpitt, 2021, The Lancet. Oncology.

Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).

S. Yusuf, J. Pogue, P. Gao, 2012, Journal of the American College of Cardiology.

Predictors of adverse outcome among patients with hypertension and coronary artery disease.

P. Kowey, G. Mancia, L. Tavazzi, 2006, Journal of the American College of Cardiology.

The Management of acute myocardial ischaemia

D. Chamberlain, P. Sleight, D. Julian, 1990 .

Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril

S. Yusuf, J. Bosch, J. Pogue, 2001, Circulation.

Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients

S. Yusuf, K. Sliwa, E. Lonn, 2014, European journal of preventive cardiology.

Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

B. Davis, R. Holman, P. Whelton, 2022, The lancet. Diabetes & endocrinology.

Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease

S. Yusuf, J. Pogue, P. Gao, 2015, Hypertension.

IS A SLOW PULSE-RATE A RELIABLE SIGN OF DIGITALIS TOXICITY?

J. Aronson, P. Sleight, P. Williams, 1978, The Lancet.

The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial

S. Yusuf, G. Dagenais, P. Gao, 2014, European journal of preventive cardiology.

Physical training enhances sympathetic and parasympathetic control of heart rate and peripheral vessels in chronic heart failure.

M. Piepoli, A. Coats, P. Sleight, 1996, Clinical science.

Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training.

M. Piepoli, S. Adamopoulos, A. Coats, 1996, Circulation.

Effects of Unilateral and Bilateral Carotid Baroreflex Stimulation on Cardiac and Neural Sympathetic Discharge Oscillatory Patterns

Raffaello Furlan, Luciano Bernardi, Peter Sleight, 2003, Circulation.

Modulatory effects of respiration

Luciano Bernardi, Peter Sleight, Lucia Spicuzza, 2001, Autonomic Neuroscience.

Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure.

B. Casadei, P. Sleight, J. Conway, 1996, Heart.

Low Doses of Scopolamine Increase Cardiac Vagal Tone in the Acute Phase of Myocardial Infarction

Peter Sleight, Barbara Casadei, Fabrizio Sessa, 1993, Circulation.

Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease.

M. Piepoli, S. Adamopoulos, A. Coats, 1992, The American journal of cardiology.

Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention: A Prospective Cohort Study of 31 546 High-Risk Individuals From 40 Countries

S. Yusuf, G. Dagenais, Á. Avezum, 2012, Circulation.

Cardiorespiratory interactions to external stimuli.

L Bernardi, P. Sleight, L. Bernardi, 2005, Archives italiennes de biologie.

A multi-country randomised trial of the role of a new telemonitoring system in CHF: the HHH study (Home or Hospital in Heart Failure). Rational, study design and protocol

P. Ponikowski, L. Tavazzi, A. Mortara, 2004 .

Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.

S. Frostick, G. Radda, B. Rajagopalan, 1987, Circulation.

Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk

S. Yusuf, K. Sliwa, E. Lonn, 2015, Hypertension.

Ramiprilof its Use in the Prevention of Cardiovascular Outcomes

W. Aronow, N. Sharpe, V. Papademetriou, 2002 .

Influenza Vaccination and Major Adverse Vascular Events in High-Risk Patients

S. Yusuf, Li-sheng Liu, Á. Avezum, 2012, Circulation.

Neural and humoral mechanisms involved in blood pressure variability.

P. Sleight, N. Boon, J. Conway, 1984, Journal of Hypertension.

Factors influencing blood pressure and heart rate variability in hypertensive humans.

J. Floras, P. Sever, M. Hassan, 1988, Hypertension.

Effects of pulsed β-stimulant therapy on β-adrenoceptors and chronotropic responsiveness in chronic heart failure

M. Piepoli, S. Adamopoulos, P. Sleight, 1995, The Lancet.

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab

R. Collins, M. Pfeffer, R. Peto, 2000, Journal of the American College of Cardiology.

Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR‐Trandolapril Study (INVEST)

E. Geiser, I. Zineh, C. Pepine, 2005, Clinical cardiology.

Isolated systolic hypertension: cardiovascular risk and treatment benefits.

P. Sleight, C. Farsang, 2001, Journal of hypertension.

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

M. Landray, R. Collins, B. Kasiske, 2019, Kidney international.

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)

M. Landray, R. Collins, B. Kasiske, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pathophysiological and clinical relevance of simplified monitoring of nocturnal breathing disorders in heart failure patients

P. Ponikowski, R. Maestri, M. L. La Rovere, 2009, European journal of heart failure.

Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.

P. Kowey, G. Mancia, S. Bangalore, 2008, American heart journal.

Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region

P. Grambsch, A. Zanchetti, H. Black, 2005, Journal of hypertension.

Current options in the management of coronary artery disease.

P. Sleight, 2003, The American journal of cardiology.

Primary prevention of coronary heart disease in hypertension

P. Sleight, 1996, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients

S. Yusuf, G. Mancia, M. Böhm, 2017, Hypertension.

2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension

Michael Böhm, Giuseppe Mancia, Diederick E Grobbee, 2014, Blood pressure.

Nonpharmacological treatments for hypertension.

P. Sleight, 2012, Journal of hypertension.

, Janice and Stroke in Patients With Coronary Artery Disease Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction

S. Yusuf, J. Pogue, P. Gao, 2014 .

Comparison of the effects of exercise and posture on the baroreflex in man.

D. J. Cunningham, T. Pickering, P. Sleight, 1971, Cardiovascular research.

Effect of Bicycling on the Baroreflex Regulation of Pulse Interval

D. J. Cunningham, T. Pickering, J. Bristow, 1971 .

Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk

S. Yusuf, C. Held, C. Anderson, 2007, Circulation.

Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart Failure)

Piotr Ponikowski, Luigi Tavazzi, Roberto Maestri, 2009, European journal of heart failure.

Lipophilic versus hydrophilic β1 blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction

B. Casadei, P. Sleight, A. Kardos, 1998, Heart.

Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era.

Roberto Maestri, Peter Sleight, Elena Robbi, 2009, Journal of the American College of Cardiology.

BLOOD PRESSURE TARGETS RECOMMENDED BY GUIDELINES AND INCIDENCE OF CARDIOVASCULAR AND RENAL EVENTS IN THE ONTARGET TRIAL: 9A.08

S. Yusuf, K. Yusoff, G. Mancia, 2011 .

Sleep and blood pressure.

A. J. Honour, W. Littler, P. Sleight, 1975, British medical journal.

Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation

R. Collins, P. Sandercock, M. Woodward, 2001 .

A new telemonitoring system in heart failure. Preliminary data from the multi-country randomized study HHH (Home or Hospital in Heart failure)

P. Ponikowski, L. Tavazzi, A. Mortara, 2006 .

[Rehabilitation and models of domiciliary care of patients with chronic heart failure: preliminary results of the HHH study].

P. Ponikowski, L. Tavazzi, R. Maestri, 2005, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

A multi-country randomised trial of the role of a new telemonitoring system in CHF: the HHH Study (Home or Hospital in Heart Failure). Preliminary data

P. Ponikowski, L. Tavazzi, A. Mortara, 2005 .

Comparison of Transthoracic Echocardiography Versus Cardiovascular Magnetic Resonance Imaging for the Assessment of Ventricular Function in Adults After Atrial Switch Procedures for Complete Transposition of the Great Arteries

R. Maestri, P. Sleight, M. Nocco, 2004 .

Atrial Natriuretic Peptide is Released by Dynamic Exercise in Man

V. Somers, S. Bloom, P. Sleight, 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

1999 WHO/ISH Hypertension Guidelines--highlights & ESH Update.

S. Kjeldsen, P. Sleight, G. Mancia, 2003, Blood pressure.

Provision of services for the diagnosis and treatment of heart disease in England and Wales. Third report of a Joint Cardiology Committee. Royal College of Physicians of London and the Royal College of Surgeons of England.

Joy, T. Treasure, D. Chamberlain, 1985, British heart journal.

The importance of the autonomic nervous system in health and disease.

P. Sleight, P Sleight, 1997, Australian and New Zealand journal of medicine.

Continuous Blood Pressure Measurement

Peter Sleight, P. Sleight, 1982 .

Long-term time-course of nocturnal breathing disorders in heart failure patients

R. Maestri, P. Sleight, P. Ponikowski, 2009, European Respiratory Journal.

Heart rate variability in acute myocardial infarction and its association with infarct site and clinical course.

M. Flather, P. Sleight, P Sleight, 1991, The American journal of cardiology.

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

E. Lonn, J. McMurray, S. Pocock, 2012, European heart journal.

Reproducibility of heart rate variability indices during exercise stress testing and inotrope infusion in chronic heart failure patients.

P. Ponikowski, M. Piepoli, S. Adamopoulos, 1996, Clinical science.

The variability of arterial pressure.

A. J. Honour, W. Littler, P. Sleight, 1978, American heart journal.

Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol

J. Floras, M. Hassan, P. Sleight, 1982, British medical journal.

Emerging Clinical Applications of Ambulatory Blood Pressure Recording

G. Mancia, J. Reid, M. Sambhi, 1993 .

Autonomic control of skin microvessels: assessment by power spectrum of photoplethysmographic waves.

A Calciati, L Bernardi, A. Coats, 1996, Clinical science.

Assessment of pulmonary ventilation scans using xenon-127 in the diagnosis of pulmonary embolism

P. Sleight, D. Croft, I. Rowe, 2004, European Journal of Nuclear Medicine.

Effects of acute and chronic beta-adrenoceptor blockade on baroreflex sensitivity in humans.

J. Floras, M. Hassan, P. Sleight, 1988, Journal of the autonomic nervous system.

Introduction

P. Sleight, J. Soler‐Soler, 1994 .

Is respiratory sinus arrhythmia a good index of cardiac vagal tone in exercise?

A. Caiazza, B. Casadei, J. Johnston, 1996, Journal of applied physiology.

Pressor responses to laboratory stresses and daytime blood pressure variability.

J. Floras, M. Hassan, P. Sleight, 1987, Journal of hypertension.

Data-monitoring committees in clinical trials

Peter Sleight, P. Sleight, 1993, The Lancet.

Reflex control of the heart.

P. Sleight, P Sleight, 1979, The American journal of cardiology.

Continuous recording of direct arterial pressure in unrestricted patients-its role in the diagnosis and management of high blood pressure.

A. J. Honour, W. Littler, P. Sleight, 1975, Clinical and experimental pharmacology & physiology.

Neurophysiology of the carotid sinus receptors in normal and hypertensive animals and man.

P. Sleight, 1976, Cardiology.

Sympathetic stimulations by exercise-stress testing and by dobutamine infusion induce similar changes in heart rate variability in patients with chronic heart failure.

M. Piepoli, S. Adamopoulos, A. Coats, 1995, Clinical science.

Pitfalls in the interpretation of spectral analysis of the heart rate variability during exercise in humans.

J Conway, B. Casadei, J. Johnston, 1995, Acta physiologica Scandinavica.

Direct Arterial Pressure and Electrocardiogram during Motor Car Driving

A. J. Honour, W. Littler, P. Sleight, 1973, British medical journal.

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination, in high risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telm

S. Yusuf, J. Pogue, C. Anderson, 2004 .

THE DIAGNOSISAND TREATMENTOF AORTICSTENOSIS COMPLICATEDBY HEART BLOCK

P. Sleight, A. Harris, C. Drew, 1965 .

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League

G. Mancia, A. Zanchetti, S. MacMahon, 1999 .

REDUCTION IN INFARCT SIZE, MORBIDITY AND SHORT-TERM MORTALITY BY EARLY INTRAVENOUS BETABLOCKADE

R. Peto, S. Yusuf, D. Ramsdale, 1983 .

Changes in the baroreceptor-cardiac reflex in exercise.

D. J. Cunningham, J. Bristow, E. Brown, 1969, The Journal of physiology.

Factors associated with in-hospital death from myocardial infarction.

P. Sleight, J. Volmink, 1997, European heart journal.

Scientific Foundations of Cardiology

P. Sleight, John V. Jones, 1985 .

THE RELEVANCE OF BAROREFLEX MECHANISMS TO THE CONTROL OF AMBULATORY AND EXERCISE BLOOD PRESSURE IN HUMANS

P. Sleight, 1989, Clinical and experimental pharmacology & physiology. Supplement.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

M. Landray, R. Collins, B. Kasiske, 2011, The Lancet.

Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials

R. Collins, B. Davis, S. Yusuf, 2015, The Lancet.

Smoking and ischaemic heart disease

E. Vartiainen, E. Falk, P. Sleight, 2014 .

Intracerebroventricular administration of cholecystokinin inhibits the activity of the dopaminergic and serotoninergic systems of the brain

P. Sleight, H. Smyth, E. Vasar, 1985, Neuroscience and Behavioral Physiology.

What is hypertension?

P. Sleight, 1971, British heart journal.

Validation of the beat to beat measurement of blood velocity in the human ascending aorta by a new high temporal resolution Doppler ultrasound spectral analyser

A. Coats, P. Sleight, AndrewJ. S. Coats, 1992, British heart journal.

No HOPE without proof: do ARBs meet the standard for cardiovascular protection?

P. Sleight, M. Shaw, A. Ralph, 2008, Medscape journal of medicine.

Are antianginal drugs effective in post-myocardial infarction secondary prevention?

P. Sleight, 1995, European heart journal.

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

M. Landray, R. Collins, B. Kasiske, 2019, Kidney international.

Early intravenous beta-blockade in myocardial infarction.

R. Peto, S. Yusuf, D. Ramsdale, 1982, British journal of clinical pharmacology.

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.

R. Collins, R. Peto, C. Baigent, 1997, The New England journal of medicine.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

M. Landray, R. Collins, B. Kasiske, 2011, The Lancet.

P. Kowey, G. Mancia, S. Bangalore, 2008, American heart journal.

S. Yusuf, G. Dagenais, Á. Avezum, 2012, Circulation.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Jeroen J. Bax, P. Kirchhof, P. Kolh, 2013, European heart journal.

MRC/BHF Heart Protection Study

R. Collins, R. Peto, S. Parish, 2002, The Lancet.

ISIS-4 - REPLY

R. Collins, R. Peto, P. Sleight, 1995 .

Jeroen J. Bax, P. Kirchhof, P. Kolh, 2007, Blood pressure.

Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures.

S. Yusuf, P. Gao, K. Teo, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Blood Pressure and Heart Rate Variability

P. Sleight, N. Boon, J. Jones, 1983 .

STREPTOKINASE IS STILL THE AGENT OF CHOICE FOR MOST PATIENTS WITH MYOCARDIAL INFARCTION

P. Sleight, 1995, American journal of therapeutics.

The effect of raising arterial blood pressure on ventilation in man.

D. J. Cunningham, T. Pickering, P. Sleight, 1969, The Journal of physiology.

S. Yusuf, G. Dagenais, Li-sheng Liu, 2010, Circulation.

Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow.

S. Frostick, B. Rajagopalan, P. Sleight, 1988, Circulation.

Defects in Signal Generation in Arterial Baroreceptors

P. Sleight, 1984 .

Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease

S. Yusuf, J. Pogue, P. Gao, 2015, Hypertension.

1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting.

G. Mancia, A. Zanchetti, C. Johnston, 1989, Bulletin of the World Health Organization.